GGrantIndex
Sort

59,101 grants matching hypertension

1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$2,775,824
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · HL

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)

$2,774,711
Thomas G Brott · Mayo Clinic Jacksonville · U01 · FY2023 · NS

MIND Diet Intervention to Prevent Alzheimer's Disease

$2,773,089
Martha C. Morris · Rush University Medical Center · R01 · FY2016 · AG

Comparative Effectiveness of Health System vs. Multilevel Interventions to Reduce Hypertension Disparities

$2,771,535
Lisa A Cooper · Johns Hopkins University · UH3 · FY2019 · HL

Clarifying the Optimal Application of SLT Therapy (COAST) Trial

$2,769,231
Stephen R Wisniewski · University Of Pittsburgh At Pittsburgh · UG1 · FY2023 · EY

Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia

$2,763,177
Titus Johannes Galama · University Of Southern California · R01 · FY2023 · AG

Hormonal, Metabolic and Signaling Interactions in PAH

$2,759,549
James E Loyd · Vanderbilt University Medical Center · P01 · FY2016 · HL

Complement Mediated Remodeling in Pulmonary Vascular Disease

$2,759,050
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2021 · HL

Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes

$2,758,396
Corette B Parker · Research Triangle Institute · U10 · FY2014 · HL

Continuation of the NuMoM2b Heart Health Study

$2,756,035
Rebecca Boehm McNeil · Research Triangle Institute · U01 · FY2025 · HL

Alzheimer's Disease Patient Registry (ADPR/ACT)

$2,755,015
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2015 · AG

Complement Mediated Remodeling in Pulmonary Vascular Disease

$2,754,196
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2023 · HL

Complement Mediated Remodeling in Pulmonary Vascular Disease

$2,754,196
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2022 · HL

CORAL: Clinical Coordinating Center

$2,753,284
Christopher J Cooper · University Of Toledo Health Sci Campus · U01 · FY2010 · HL

Molecular Genetic Approaches in Atherosclerosis Research

$2,750,090
Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2015 · HL

NCHS-CDC NHIS Taste & Smell and NHIS Voice, Speech, and Language Questionnaire Supplements

$2,750,000
Stephen Blumberg · National Institute On Deafness And Other Communication Disorders · Y01 · FY2021 · DC

Genetic Epidemiological Studies of Alzheimer Disease

$2,740,882
Boston University Medical Campus · R01 · FY2005 · AG

Sleep in Neurocognitive Aging and Alzheimers Research (SANAR)

$2,731,475
Alberto Rafael Ramos · University Of Miami School Of Medicine · R01 · FY2022 · AG

Clinical Coordination Center for STEADY-PD3

$2,730,128
Tanya Simuni Simuni · Northwestern University At Chicago · U01 · FY2014 · NS

PROGRAM OF EXCELLENCE IN MOLECULAR BIOLOGY

$2,726,720
Massachusetts Institute Of Technology · P01 · FY2000 · HL

Framingham Project/Levy

$2,722,934
Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL

Framingham Project/Levy

$2,717,328
Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,714,385
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · HL

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma

$2,713,467
Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD

Therapeutic Targeting of Vascular Subphenotypes of Lung Disease

$2,713,336
Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · HL